Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
Tunicamycin, an inhibitor of glycosylation, was used to examine the role of carbohydrate moieties of glycoproteins involved in recognition of Simian virus 40 (SV40)-transformed cells by cytotoxic T lymphocytes (CTL). Tunicamycin treatment renders such cells refractory to lysis by H-2 restricted, SV40-specific CTL as well as by allogeneic CTL directed only against H-2 antigens. Treated cells are no longer susceptible to lysis by anti-H-2 antisera and complement, nor are they stained by monoclonal anti-H-2 antibodies in an indirect immunofluorescence assay. No accumulation of H-2 proteins was detected in immunoprecipitates from cells labeled with [35S]methionine in the presence of tunicamycin. It is concluded that tunicamycin prevents the expression of H-2 glycoproteins in these cells, perhaps due to accelerated degradation of the unglycosylated molecules.